Intellectual Property

Congress should ratify the proposed USMCA and in particular support its provision requiring 10 years of data protection for biologic drugs. The result will be a more competitive U.S. biopharmaceutical industry, more high-paying American jobs and more incentives to produce new cures.
Intellectual Property
Check a box to narrow search for individual content items that cover numerous issues.
March 4, 2009
ITIF argues that Congress should promote technology neutral policies that do not unfairly advantage or disadvantage any particular technology or business model.
May 22, 2008
The growing array of mercantilist trade policies that nations have enacted to unfairly disadvantage foreign – including U.S. – technology products.
June 7, 2007
Featuring a presentation from Ian Fletcher, Chief Executive, UK Office of Intellectual Property, followed by a discussion moderated by ITIF President Dr. Robert Atkinson. The Forum took place at ITIF offices in Washington, DC.
May 22, 2007
Representative Adam Schiff (D-CA), ITIF President Rob Atkinson and ITIF Senior Analyst Julie Hedlund spoke at an ITIF event to release a new ITIF report on patent reform at the Rayburn House Office Building, Room 2226, in Washington, D.C.
May 22, 2007
Focuses on three areas of reform: patent delay, patent quality and the reasons why the PTO issues too many questionable patents, and the dramatic increase in patent litigation and awards.
May 10, 2007
ITIF President Rob Atkinson and Senior Analyst Daniel Castro spoke at an ITIF event marking the release of a new ITIF report. See details and video from the event.
May 10, 2007
ITIF describes the current copyright system and the problems with the recent the Copyright Royalty Board (CRB) ruling.
March 26, 2007
On Monday, March 26, 2007, New York Law School Professor Beth Noveck, Marc Williams, Governmental Programs Executive, IBM and Kaz Kazenske, Senior Director, Microsoft, spoke at an ITIF Policy Forum on the Peer to Patent Project and Patent Reform.

Pages